This is the authors' abstract. We don't add key points for this paper.
Alcohol-associated liver disease (ALD) is a major public health concern, causing 0.9% of all deaths in 2010.1 In some cases, ALD can progress to alcoholic hepatitis, which presents as acute-on-chronic liver failure and has limited treatment options.2 Reports of changes in alcohol consumption and increases in severe ALD during the COVID-19 pandemic reinforce the urgent need to provide therapeutic targets and develop new treatments for ALD.3
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mackowiak et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: